Sept 28 (Reuters) - Johnson & Johnson (JNJ.N), opens new tab said its cancer drug combination increased the time patients with a type of non small-cell lung cancer live without the disease worsening ...
March 1 (Reuters) - The U.S. health regulator on Friday approved Johnson & Johnson's (JNJ.N), opens new tab therapy in combination with other chemotherapies for the first-line treatment of a type of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback